- Home
- ATKR vs DYN Comparison
ATKR vs DYN Comparison
Compare ATKR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATKR
- DYN
- Stock Information
- Founded
- ATKR 1959
- DYN 1984
- Country
- ATKR United States
- DYN United States
- Employees
- ATKR N/A
- DYN N/A
- Industry
- ATKR Industrial Machinery/Components
- DYN Medicinal Chemicals and Botanical Products
- Sector
- ATKR Miscellaneous
- DYN Health Care
- Exchange
- ATKR Nasdaq
- DYN Nasdaq
- Market Cap
- ATKR 3.0B
- DYN 3.4B
- IPO Year
- ATKR 2016
- DYN 2020
- Fundamental
- Price
- ATKR $89.04
- DYN $28.39
- Analyst Decision
- ATKR Buy
- DYN Strong Buy
- Analyst Count
- ATKR 5
- DYN 9
- Target Price
- ATKR $131.60
- DYN $52.44
- AVG Volume (30 Days)
- ATKR 616.8K
- DYN 1.0M
- Earning Date
- ATKR 11-21-2024
- DYN 11-12-2024
- Dividend Yield
- ATKR 1.44%
- DYN N/A
- EPS Growth
- ATKR N/A
- DYN N/A
- EPS
- ATKR 14.24
- DYN N/A
- Revenue
- ATKR $3,283,645,000.00
- DYN N/A
- Revenue This Year
- ATKR N/A
- DYN N/A
- Revenue Next Year
- ATKR N/A
- DYN N/A
- P/E Ratio
- ATKR $6.25
- DYN N/A
- Revenue Growth
- ATKR N/A
- DYN N/A
- 52 Week Low
- ATKR $80.11
- DYN $9.82
- 52 Week High
- ATKR $194.98
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- ATKR 47.05
- DYN 42.04
- Support Level
- ATKR $85.87
- DYN $27.99
- Resistance Level
- ATKR $105.28
- DYN $35.68
- Average True Range (ATR)
- ATKR 3.79
- DYN 2.09
- MACD
- ATKR -0.14
- DYN 0.23
- Stochastic Oscillator
- ATKR 20.27
- DYN 9.12
About ATKR Atkore Inc.
Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments: electrical and safety and infrastructure. Net sales are highest in the electrical business line as well as in the United States. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tube, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.